Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC

Conditions

• Head and Neck Squamous Cell Carcinoma
• Neoadjuvant Therapy

Interventions

• DRUG: 3cycles (Toripalimab + cetuximab)
• PROCEDURE: Surgery
• RADIATION: Radiotherapy or chemoradiotherapy

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology